Author | Rose Schneider Krivich

Articles

Anti-seizure drug gets boxed warning for eye damage risks

The FDA has approved changes to the drug label of the anti-seizure drug ezogabine (Potiga), underscoring risks of abnormalities to the retina in the eye, potential vision loss, and skin discoloration-all of which may become permanent.